Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hatem A Azim

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Oncology and Therapy|September 21, 2023
The Landscape of BRCA Mutations among Egyptian Women with Breast CancerHamdy A Azim, Samah A Loutfy, Hatem A Azim, et al.
Endocrine-Related Cancer|May 15, 2014
Biology of breast cancer during pregnancy using genomic profilingHatem A Azim, Sylvain Brohée, Fedro A Peccatori, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2011
The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control studyHatem A Azim, Edoardo Botteri, Giuseppe Renne, et al.
Journal of the National Cancer Institute|November 1, 2017
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor StatusMatteo Lambertini, Niels Kroman, Lieveke Ameye, et al.
The Lancet. Oncology|April 30, 2026
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trialsMohammed S Beshr, Ammar Fahaid, Rana H Shembesh, et al.
Breast (Edinburgh, Scotland)|January 3, 2025
Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohortBryan F Vaca-Cartagena, Ana S Ferrigno Guajardo, Hatem A Azim, et al.
British Journal of Cancer|November 2, 2016
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patientsMatteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Dissecting the heterogeneity of triple-negative breast cancerOtto Metzger-Filho, Andrew Tutt, Evandro de Azambuja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective studyHatem A Azim, Niels Kroman, Marianne Paesmans, et al.
The Lancet. Oncology|June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trialMartine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Oncology and Therapy|September 21, 2023
The Landscape of BRCA Mutations among Egyptian Women with Breast CancerHamdy A Azim, Samah A Loutfy, Hatem A Azim, et al.
Endocrine-Related Cancer|May 15, 2014
Biology of breast cancer during pregnancy using genomic profilingHatem A Azim, Sylvain Brohée, Fedro A Peccatori, et al.
Acta Oncologica (Stockholm, Sweden)|December 17, 2011
The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control studyHatem A Azim, Edoardo Botteri, Giuseppe Renne, et al.
Journal of the National Cancer Institute|November 1, 2017
Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor StatusMatteo Lambertini, Niels Kroman, Lieveke Ameye, et al.
The Lancet. Oncology|April 30, 2026
CDK4/6 inhibitors plus endocrine therapy versus endocrine monotherapy in hormone receptor-positive, HER2-negative advanced breast cancer: a reconstructed individual patient data meta-analysis of phase 3 randomised controlled trialsMohammed S Beshr, Ammar Fahaid, Rana H Shembesh, et al.
Breast (Edinburgh, Scotland)|January 3, 2025
Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohortBryan F Vaca-Cartagena, Ana S Ferrigno Guajardo, Hatem A Azim, et al.
British Journal of Cancer|November 2, 2016
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patientsMatteo Lambertini, Ana Catarina Pinto, Lieveke Ameye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Dissecting the heterogeneity of triple-negative breast cancerOtto Metzger-Filho, Andrew Tutt, Evandro de Azambuja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2012
Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective studyHatem A Azim, Niels Kroman, Marianne Paesmans, et al.
The Lancet. Oncology|June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trialMartine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
Pageof 14